Patents Assigned to Cidara Therapeutics, Inc.
  • Compositions and methods for the treatment of viral infections
    Patent number: 11833213
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: December 5, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: James M. Balkovec, Daniel C. Bensen, Allen Borchardt, Thomas P. Brady, Zhi-Yong Chen, Jason Cole, Quyen-Quyen Thuy Do, Simon Doehrmann, Wanlong Jiang, Thanh Lam, Alain Noncovich, Leslie W. Tari
  • Compositions and methods for the treatment of fungal infections
    Patent number: 11819533
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: November 21, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, David Hughes, Martin Patrick Hughes, Navdeep B. Malkar, Balasingam Radhakrishnan, Anuradha Vaidya
  • Dosing regimens for treatment of fungal infections
    Patent number: 11712459
    Abstract: The disclosure features pharmaceutical compositions, methods, and kits featuring dosing regimens and CD101, or a pharmaceutical acceptable salt or neutral form thereof (e.g., CD101 acetate).
    Type: Grant
    Filed: March 15, 2017
    Date of Patent: August 1, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, Jeffrey Brian Locke, Voon Ong, Taylor Sandison, Dirk Thye
  • Dosing regimens for echinocandin class compounds
    Patent number: 11654196
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: May 23, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Synthesis of echinocandin antifungal agent
    Patent number: 11524980
    Abstract: The present invention relates to echinocandin cyclopeptides and to methods for preparing echinocandin cyclopeptides.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: December 13, 2022
    Assignee: Cidara Therapeutics, Inc.
    Inventors: David Hughes, Martin Patrick Hughes, Robert Michael Hughes, Balasingam Radhakrishnan, Yannick Borguet, Steven McIntyre
  • Compositions and methods for the treatment of viral infections
    Patent number: 11510992
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: November 29, 2022
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Allen Borchardt, Thomas P. Brady, Zhi-Yong Chen, Thanh Lam, Leslie W. Tari
  • Compositions and methods for the treatment of fungal infections
    Patent number: 11197909
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: December 14, 2021
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, David Hughes, Martin Patrick Hughes, Navdeep B. Malkar, Balasingam Radhakrishnan, Anuradha Vaidya
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
    Publication number: 20210228727
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Application
    Filed: March 5, 2021
    Publication date: July 29, 2021
    Applicants: Cidara Therapeutics, Inc., Cidara Therapeutics, Inc.
    Inventors: James M. BALKOVEC, Daniel C. BENSEN, Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Jason COLE, Quyen-Quyen Thuy DO, Simon DOEHRMANN, Wanlong JIANG, Thanh LAM, Alain NONCOVICH, Leslie W. TARI
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS
    Publication number: 20210220478
    Abstract: Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).
    Type: Application
    Filed: March 5, 2021
    Publication date: July 22, 2021
    Applicant: Cidara Therapeutics, Inc.
    Inventors: James M. BALKOVEC, Daniel C. BENSEN, Allen BORCHARDT, Thomas P. BRADY, Zhi-Yong CHEN, Jason COLE, Quyen-Quyen Thuy DO, Simon DOEHRMANN, Wanlong JIANG, Thanh LAM, Alain NONCOVICH, Leslie W. TARI
  • Methods for preventing and treating pneumocystis infections
    Patent number: 10780144
    Abstract: The disclosure relates to methods of prophylactic and therapeutic treatments of a Pneumocystis infection (i.e., an infection caused by Pneumocystis jirovecii) in a subject by administering to the subject a compound of any of formulas (I)-(III) (e.g., a salt of Compound 1, or a neutral form thereof). The disclosure also relates to methods of inhibiting the replication of a Pneumocystis spp. The methods of the disclosure can be useful in immunocompromised subjects.
    Type: Grant
    Filed: August 1, 2019
    Date of Patent: September 22, 2020
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, Voon Ong, Maureen Roden, Taylor Sandison, Dirk Thye
  • Dosing regimens for echinocandin class compounds
    Patent number: 10702573
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: July 7, 2020
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Methods for preventing and treating pneumocystis infections
    Patent number: 10369188
    Abstract: The disclosure relates to methods of prophylactic and therapeutic treatments of a Pneumocystis infection (i.e., an infection caused by Pneumocystis jirovecii) in a subject by administering to the subject a compound of any of formulas (1)-(111) (e.g., a salt of Compound 1, or a neutral form thereof). The disclosure also relates to methods of inhibiting the replication of a Pneumocystis spp. The methods of the disclosure can be useful in immunocompromized subjects.
    Type: Grant
    Filed: January 6, 2017
    Date of Patent: August 6, 2019
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, Voon Ong, Maureen Roden, Taylor Sandison, Dirk Thye
  • Dosing regimens for echinocandin class compounds
    Patent number: 10016479
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: July 10, 2018
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Antifungal agents and uses thereof
    Patent number: 9676821
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: June 13, 2017
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Duke James, Jr., Christopher Patrick Laudeman, Navdeep Balkrishna Malkar, Balasingam Radhakrishnan
  • Dosing regimens for echinocandin class compounds
    Patent number: 9526835
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 27, 2016
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS
    Publication number: 20160213742
    Abstract: Compositions and methods for the treatment of fungal infections including compounds containing a pathogen pattern recognition receptor ligand and a ? 1,3-glucan synthase inhibitor are disclosed. In particular, compounds containing a lipopeptide moiety and a formyl peptide receptor ligand can be used in the treatment of fungal infections caused by a fungus of the genus Aspergillus or Candida.
    Type: Application
    Filed: September 4, 2014
    Publication date: July 28, 2016
    Applicants: Cidara Therapeutics, Inc., Cidara Therapeutics, Inc.
    Inventors: Kevin Michael FORREST, James Kevin JUDICE, H. Shaw WARREN, James Michael BALKOVEC, Thomas Patrick BRADY
  • Antifungal agents and uses thereof
    Patent number: 9217014
    Abstract: The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections.
    Type: Grant
    Filed: April 1, 2014
    Date of Patent: December 22, 2015
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Duke James, Jr., Christopher Patrick Laudeman, Navdeep Balkrishna Malkar, Balasingam Radhakrishnan
  • DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS
    Publication number: 20150087583
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: March 14, 2013
    Publication date: March 26, 2015
    Applicant: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, JR., Anuradha Vaidya, Karen Polowy